• Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Average Rating of "Buy" by Analysts

    المصدر: Buzz FX / 07 فبراير 2025 05:07:10   America/Chicago


    Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Average Rating of "Buy" by Analysts Written by MarketBeat February 7, 2025 Share Link copied to clipboard. Aclaris Therapeutics, Inc. ( NASDAQ:ACRS - Get Free Report ) has been assigned an aver
    Read more...
شارك على،